Huang Y, Wang Q-l, Cheng D-d, Xu W-T, Lu N-H. Adhesion and Invasion of gastric mucosa epithelial cells by Helicobacter pylori. Front Cell Infect Microbiol. 2016;6:159.
Article
Google Scholar
Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG clinical guideline: treatment of Helicobacter pylori infection. Off J Am Coll Gastroenterology|ACG. 2017;112:212–39.
Google Scholar
Pimentel-Nunes P, Libânio D, Marcos-Pinto R, Areia M, Leja M, Esposito G, et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): european society of gastrointestinal endoscopy (ESGE), european Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy. 2019;51:365–88.
Article
Google Scholar
Banić M, Franceschi F, Babić Z, Gasbarrini A. Extragastric manifestations of Helicobacter pylori Infection. Helicobacter. 2012;17:49–55.
Article
Google Scholar
Bilardi C, Dulbecco P, Zentilin P, Reglioni S, Iiritano E, Parodi A, et al. A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial. Clin Gastroenterol Hepatol. 2004;2:997–1002.
Article
CAS
Google Scholar
Peedikayil MC, AlSohaibani FI, Alkhenizan AH. Levofloxacin-based first-line therapy versus Standard First-Line therapy for Helicobacter pylori eradication: meta-analysis of randomized controlled trials. PLoS ONE. 2014;9:e85620.
Article
Google Scholar
O’Connor JPA, Taneike I, O’Morain C, Review. Improving compliance with Helicobacter pylori eradication therapy: when and how? Therap Adv Gastroenterol. 2009;273–9.
Li J, Deng J, Wang Z, Li H, Wan C. Antibiotic resistance of Helicobacter pylori strains isolated from pediatric patients in Southwest China. Front Microbiol. 2021;11:621791.
Article
Google Scholar
Megraud F, Coenen S, Versporten A, Kist M, Lopez-Brea M, Hirschl AM, et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut. 2013;62:34–42.
Article
CAS
Google Scholar
Butler CC, Dorward J, Yu L-M, Gbinigie O, Hayward G, Saville BR, et al. Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet. 2021;397:1063–74.
Article
Google Scholar
Min J-Y, Jang YJ. Macrolide therapy in respiratory viral infections. Mediators Inflamm. 2012;2012:e649570.
Article
Google Scholar
Taylor L. Covid-19: antimicrobial misuse in Americas sees drug resistant infections surge, says WHO. BMJ. 2021;375:n2845.
Elsayed AA, Darwish SF, Zewail MB, Mohammed M, Saeed H, Rabea H. Antibiotic misuse and compliance with infection control measures during COVID-19 pandemic in community pharmacies in Egypt. Int J Clin Pract. 2021;75:e14081.
Article
CAS
Google Scholar
Wang YK, Kuo FC, Liu CJ, Wu MC, Shih HY, Wang SS, et al. Diagnosis of Helicobacter pylori infection: current options and developments. World J Gastroenterol. 2015;21:11221–35.
Article
CAS
Google Scholar
Ierardi E, Losurdo G, Fortezza RFL, Principi M, Barone M, Leo AD. Optimizing proton pump inhibitors in Helicobacter pylori treatment: old and new tricks to improve effectiveness. World J Gastroenterol. 2019;25:5097–104.
Article
CAS
Google Scholar
Hafeez M, Qureshi ZA, Khattak AL, Saeed F, Asghar A, Azam K, et al. Helicobacter Pylori eradication therapy: still a challenge. Cureus. 2021;13:e14872.
Google Scholar
Peterson WL, Fendrick AM, Cave DR, Peura DA, Garabedian-Ruffalo SM, Laine L. Helicobacter pylori-related disease: guidelines for testing and treatment. Arch Intern Med. 2000;160:1285–91.
Article
CAS
Google Scholar
Nayar DS. Current eradication rate of Helicobacter pylori with clarithromycin-based triple therapy in a gastroenterology practice in the New York metropolitan area. Infect Drug Resist. 2018;11:205–11.
Article
CAS
Google Scholar
Yuan Y, Ford AC, Khan KJ, Gisbert JP, Forman D, Leontiadis GI, et al. Optimum duration of regimens for Helicobacter pylori eradication. Cochrane Database Syst Rev. 2013;2013:CD008337.
Google Scholar
Gatta L, Vakil N, Vaira D, Scarpignato C. Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy. BMJ. 2013;347:f4587.
Article
Google Scholar
Azab ET, Thabit AK, McKee S, Al-Qiraiqiri A. Levofloxacin versus clarithromycin for Helicobacter pylori eradication: are 14 day regimens better than 10 day regimens? Gut Pathog. 2022;14:24.
Article
CAS
Google Scholar
Tai W-C, Chiu C-H, Liang C-M, Chang K-C, Kuo C-M, Chiu Y-C, et al. Ten-day versus 14-Day levofloxacin-containing triple therapy for second-line anti-Helicobacter pylori eradication in Taiwan. Gastroenterol Res Pract. 2013;2013:932478.
Article
Google Scholar
Elantouny NG, Abo Bakr AA, EL-Sokkary RH, Elshahat YE. Levofloxacin versus clarithromycin-based therapy for eradication of Helicobacter pylori infection: a comparative study. Zagazig Univ Med J. 2019;25:500–7.
Article
Google Scholar
Awad Y, Eldeeb M, Fathi M, Mahmoud N, Morsy R. Helicobacter pylori antibiotic resistance patterns among Egyptian children and predictors of resistance. QJM-Int J Med. 2020;113:hcaa063.021.
Article
Google Scholar
Ng YL, Salim CK, Chu JJH. Drug repurposing for COVID-19: approaches, challenges and promising candidates. Pharmacol Ther. 2021;228:23.
Article
Google Scholar
Garg SK. Antibiotic misuse during COVID-19 pandemic: a recipe for disaster. Indian J Crit Care Med. 2021;25:617.
Article
CAS
Google Scholar
Nag VL, Kaur N. Superinfections in COVID-19 patients: role of antimicrobials. Dubai Med J. 2021;4:117–26.
Article
Google Scholar
Lai CC, Chen SY, Ko WC, Hsueh PR. Increased antimicrobial resistance during the COVID-19 pandemic. J Antimicrob Agents. 2021;57:106324.
Article
CAS
Google Scholar
Fu Y, Yang Q, Xu M, Kong H, Chen H, Fu Y, et al. Secondary bacterial infections in critical Ill patients with Coronavirus Disease 2019. Open Forum Infect Dis. 2020;7:ofaa220.
Article
Google Scholar
Li J, Wang J, Yang Y, Cai P, Cao J, Cai X, et al. Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Wuhan, China: a retrospective analysis. Antimicrob Resist Infect Control. 2020;9:153.
Article
Google Scholar
Flores-Treviño S, Mendoza-Olazarán S, Bocanegra-Ibarias P, Maldonado-Garza HJ, Garza-González E. Helicobacter pylori drug resistance: therapy changes and challenges. Expert Rev Gastroenterol Hepatol. 2018;12:819–27.
Article
Google Scholar
Yacouba A, Olowo-Okere A, Yunusa I. Repurposing of antibiotics for clinical management of COVID-19: a narrative review. Ann Clin Microbiol. 2021;20:1–8.
Google Scholar
Bleyzac N, Goutelle S, Bourguignon L, Tod M. Azithromycin for COVID-19: more than just an Antimicrobial? Clin Drug Investig. 2020;40:683–6.
Article
CAS
Google Scholar
Fass R. Erythromycin, clarithromycin, and azithromycin: use of frequency distribution curves, scattergrams, and regression analyses to compare in vitro activities and describe cross-resistance. Antimicrob Agents Chemother. 1993;37:2080–6.
Article
CAS
Google Scholar
Tshibangu-Kabamba E, Yamaoka Y. Helicobacter pylori infection and antibiotic resistance from biology to clinical implications. Nat Rev Gastroenterol Hepatol. 2021;18:613–29.
Article
Google Scholar
Karampela I, Dalamaga M. Could respiratory Fluoroquinolones, Levofloxacin and Moxifloxacin, prove to be beneficial as an Adjunct Treatment in COVID-19? Arch Med Res. 2020;51:741–2.
Article
CAS
Google Scholar
Alboraie M, Elhossary W, Aly OA, Abbas B, Abdelsalam L, Ghaith D, et al. Egyptian recommendations for management of Helicobacter pylori infection: 2018 report. Arab J Gastroenterol. 2019;20:175–9.
Article
Google Scholar
Malfertheiner P, Megraud F, O’morain C, Gisbert J, Kuipers E, Axon A, et al. Management of Helicobacter pylori infection—the Maastricht V/Florence consensus report. Gut. 2017;66:6–30.
Article
CAS
Google Scholar
Shah SC, Iyer PG, Moss SF. AGA clinical practice update on the management of refractory Helicobacter pylori infection: expert review. Gastroenterology. 2021;160:1831–41.
Article
Google Scholar
Taha SHN, Moawad AM, Ghazy RM, Abdelhalim WA. Assessment of self-treatment knowledge, beliefs and practice during COVID-19 pandemic among Egyptian population: a cross sectional study. Egypt J Hosp Med. 2022;89:4516–25.
Article
Google Scholar
Kazemi S, Tavakkoli H, Habizadeh MR, Emami MH. Diagnostic values of Helicobacter pylori diagnostic tests: stool antigen test, urea breath test, rapid urease test, serology and histology. J Res Med Sci. 2011;16:1097–104.
CAS
Google Scholar
Redéen S, Petersson F, Törnkrantz E, Levander H, Mårdh E, Borch K. Reliability of diagnostic tests for Helicobacter pylori infection. Gastroenterol Res Pract. 2011;2011:940650.
Article
Google Scholar